What is the extra meant to achieve?
A fertility treatment plan can grow quickly. An additional test appears, followed by a laboratory technique or another procedure, and the patient is left trying to decide which extras are worth considering.
The Human Fertilisation and Embryology Authority maintains a public resource on treatment add-ons, last reviewed on 25 September 2026. Its ratings assess evidence for particular outcomes and, in some cases, particular patient groups. That detail matters more than treating a colour as a universal verdict on an entire treatment.
Read the outcome beside the rating
Start with the full name of the proposed add-on. Ask the clinic to explain the intended benefit in your case and which published evidence supports that expectation. Improving one laboratory measure is a different claim from improving the chance of having a baby.
The HFEA uses five ratings to distinguish evidence of benefit, conflicting or insufficient evidence, lack of effect and potential harm or reduced effectiveness. A lack of evidence should not be presented as proof that an extra will help. Equally, a rating needs to be read with its accompanying explanation.
Put the price next to that explanation. A patient can then discuss the choice without losing sight of the rest of the treatment budget. This is particularly useful abroad, where translation or a differently named package may make it harder to recognise what is being offered.
Leave room for a considered answer
Request the proposal early enough to read it away from the payment desk. If two clinics suggest different extras, take the two written plans to a qualified fertility specialist and ask about the reasoning behind each.
The useful conversation is personal and specific: what problem is this intended to address, what remains uncertain, and what happens if you decline it? The HFEA resource provides a starting point for that discussion, while the treating clinician must explain how the evidence relates to your circumstances.
Questions to take with you
- Which outcome is this add-on intended to improve for me?
- Does the evidence concern patients with my circumstances?
- How would my plan and quotation change if I declined it?
Sources & further reading
Further reading from the medical, regulatory and specialist organisations cited in this article.
How we approach our content
